Diagnostic accuracy of 18F Prostate Specific Membrane Antigen (PSMA) PET-CT radiotracers in staging and restaging of high-risk prostate cancer patients and patients with biochemical recurrence: protocol for an overview of reviews [version 1; peer review: 2 approved]

Background: Correct staging and risk stratification is essential in ensuring prostate cancer patients are offered the most appropriate treatment. Interest has been growing in the use of radiotracers targeting prostate specific membrane antigen (PSMA), including the use of 18F-PSMA PET-CT, as part of...

Full description

Bibliographic Details
Published in:HRB Open Research
Main Authors: Susan Ahern, Kieran A. Walsh, Lydia O'Sullivan, Andrew Dullea, Máirín Ryan, Kirsty O'Brien, Patricia Harrington, Susan M. Smith, Marie Carrigan, Maeve McGarry
Format: Article
Language:English
Published: F1000 Research Ltd 2023-09-01
Subjects:
Systematic Review
overview of reviews
prostate cancer
justification
PSMA
PET-CT
eng
Online Access:https://hrbopenresearch.org/articles/6-57/v1

Internet

https://hrbopenresearch.org/articles/6-57/v1

Similar Items